Valuation : ZIM Laboratories Limited

Market Cap 6.85B 72.52M 62.3M 58.54M 53.55M 99.94M 101M 691M 269M 3.51B 272M 266M 11.27B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 7.71B 81.66M 70.15M 65.91M 60.29M 113M 113M 778M 303M 3.95B 307M 300M 12.69B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.77%
Yield 2025 *
-
Yield 2026 -
1 day-4.23%
1 week+1.91%
Current month+3.48%
1 month+12.43%
3 months+25.75%
6 months+86.57%
Current year+77.98%
1 week 112
Extreme 112
136.8
1 month 105.8
Extreme 105.8
136.8
Current year 59.72
Extreme 59.72
136.8
1 year 59.72
Extreme 59.72
136.8
3 years 59.72
Extreme 59.72
136.8
5 years 36.37
Extreme 36.366666
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - 2019-03-31
Director of Finance/CFO - 1990-12-31
Director TitleAgeSince
Chairman - 1989-12-31
Director/Board Member - 1990-12-31
Director/Board Member - 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-4.23%+1.91%+68.36%-1.35% 75.73M
-0.81%+0.87%+22.41%+72.77% 49.06B
+0.41%+0.12%+52.20%+121.38% 40.37B
-0.97%-0.61%+14.75%+86.17% 12.19B
-1.28%-0.57%-11.12%+11.99% 12.08B
+0.57%+0.95%+29.02%+153.11% 9.14B
+0.08%-3.68%+23.29%+42.89% 7.36B
-0.04%+0.85%+28.15%+224.81% 7.35B
+0.81%-0.04%+45.87%-10.06% 7.32B
+0.03%-1.75%-40.80%+14.39% 5.19B
Average -0.54%+0.39%+23.21%+71.61% 15.01B
Weighted average by Cap. -0.26%+0.37%+26.81%+86.82%

Financials

2025 2026
Net sales 3.79B 40.13M 34.47M 32.39M 29.63M 55.3M 55.74M 383M 149M 1.94B 151M 147M 6.24B 3.74B 39.63M 34.04M 31.99M 29.26M 54.61M 55.04M 378M 147M 1.92B 149M 146M 6.16B
Net income 122M 1.29M 1.11M 1.04M 951K 1.77M 1.79M 12.28M 4.78M 62.28M 4.84M 4.73M 200M 58.38M 618K 531K 499K 456K 852K 858K 5.89M 2.29M 29.89M 2.32M 2.27M 96.04M
Net Debt 1.16B 12.25M 10.53M 9.89M 9.05M 16.89M 17.02M 117M 45.47M 593M 46.01M 45M 1.9B 863M 9.14M 7.85M 7.37M 6.74M 12.59M 12.69M 87.09M 33.9M 442M 34.3M 33.55M 1.42B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
26-09-03 ₹127.95 -4.23% 14,352
26-09-02 ₹133.60 +12.36% 51,670
26-09-01 ₹118.90 -3.84% 1,968
26-08-31 ₹123.65 -1.08% 7,885
26-08-28 ₹125.00 +0.16% 2,439
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock